3Terada H, Kamata N. Contribution of the combination of(201)T1 SPECT and (99m)T (c)0(4)(-) SPECT to the differential diagnosis of brain tumors and tumor and tumor-like lesions. A preliminary report[J].J Neuroradiol, 2003, 30:91-94.
4Kanner A A, Marchi N, Fazio V, et al.Serum Sl00beta:a noninvasive marker of blood-brain barrier function and brain lesions[J].Cancer, 2003, 97:2806-2813.
5Kranz B R. Detection of rate malignant cells and their apoptotic fragments in cerebrospinal fluid[J]. Lancet, 2000, 356:1242-1244.
6Sanz M, Loeoco F, Martin G, et al. Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytie leukemia: A joint study of the PETHEMA and GIMEMA cooperative groups. Blood, 2000 ;96 ( 4 ) : 1247-53.
7Freireich E. Targeting leukemia: from bench to beside. Leukemia, 1998 ; 12( suppl I ) :56-66.
8Waber D P. Carpentieri S C. Klar N, et al. Cognitive sequelae in children treated for acute lymphoblastic leukemia with dexamethasone or prednisene..Ioumal of Pediatric Hematology Oneology, 2000;22 (22) :193-196.
9Mantadakis E, Samonis G, Kalmanti M. A Comprehensive review of acute promyelocytie leukemia in children. Aeta Haematol, 2008 ; 119 (2) :73-82.
10Giorgina Specchia, Francesco Albanoa, Silvana Guerrierob, et al. Retinal Abnormalities in Newly Diagnosed Adult Acute Myeloid Leukemia. Acta Haematot, 2001 ; 105:197-203.
